B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CHRM2

MOLECULAR TARGET

cholinergic receptor muscarinic 2

UniProt: P08172NCBI Gene: 112957 compounds

CHRM2 (cholinergic receptor muscarinic 2) is targeted by 57 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CHRM2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Hyoscyamine4.5291
2Arecoline3.9551
3N-Methylscopolamine3.4330
4Pilocarpine3.0921
5Scopolamine2.9418
6Muscarine2.7114
7Hyoscyamine2.309
8Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent1.956
9Quetiapine Fumarate1.795
10hexahydrosiladiphenidol1.795
11Ipratropium1.614
12Mianserin1.393
13Loxapine1.393
14Promethazine1.393
15Strychnine1.393
16Tolterodine Tartrate1.393
17Cyproheptadine1.102
18Dimethindene1.102
19ethopropazine1.102
20Nortriptyline1.102
21protriptyline1.102
22cbd0.691
23Quercetin0.691
24Amoxapine0.691
25Aripiprazole0.691
26Astemizole Antihistamine drug now withdrawn from0.691
27Axitinib0.691
28Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
29Benzydamine0.691
30Butaclamol0.691
31candesartan cilexetil [Supplementary Concept]0.691
32cannabidiol0.691
33Chlorpheniramine0.691
34Cinnarizine0.691
35Cyclizine0.691
36Dequalinium0.691
37Desogestrel0.691
38dofetilide0.691
39Flunarizine Flunarizine is0.691
40Gabexate0.691
41Hydroxyzine0.691
42Ibogaine0.691
43Ivabradine0.691
44Levallorphan0.691
45Loratadine0.691
46Metergoline0.691
47Nicergoline0.691
48Niclosamide0.691
49Norethindrone Acetate Acetate ester of norethindrone that is used as0.691
50oxatomide [Supplementary Concept] structure;0.691

Showing top 50 of 57 compounds. Use the BiohacksAI search to explore all CHRM2 modulators.

About CHRM2 as a Drug Target

CHRM2 (cholinergic receptor muscarinic 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 57 compounds with documented CHRM2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CHRM2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.